Korean J Ophthalmol.  2014 Aug;28(4):356-357.

Pseudohypopyon after Management of Posterior Capsule Rupture Using Intracameral Triamcinolone Injection in Cataract Surgery

• Lee SJ
• Kim YD
• Kyung H

Abstract

No abstract available.

MeSH Terms

Anterior Chamber/drug effects/*pathology
Eye Diseases/*chemically induced/physiopathology
Female
Glucocorticoids/administration & dosage/*adverse effects
Humans
Injections, Intraocular
Lens Implantation, Intraocular
Middle Aged
Phacoemulsification/*adverse effects
Posterior Capsular Rupture, Ocular/*diagnosis/etiology
Prolapse
Suppuration/*chemically induced/physiopathology
Triamcinolone Acetonide/administration & dosage/*adverse effects
Vitrectomy
Vitreous Body
Glucocorticoids
Triamcinolone Acetonide

Figure

• 

  Fig. 1 Yellow-whitish deposits seen in the anterior chamber 1 day following cataract surgery with triamcinolone acetonide for visualizing prolapsed vitreous body due to posterior capsule rupture. Some triamcinolone acetonide particles were seen on the intraocular lens surface.

Reference

1. Burk SE, Da Mata AP, Snyder ME, et al. Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg. 2003; 29:645–651.

2. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol. 2000; 84:1064–1067.

3. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol. 2003; 121:1279–1282.